The consumer health company also disclosed its CEO’s departure, following its CFO replacement earlier this year, and appointed an interim chief executive. Preliminary second-quarter 2025 results show ...

With activist investor Starboard Value holding a seat on Kenvue’s board of directors, the consumer healthcare company is ...

Alongside the leadership change, Kenvue revealed that its Board had previously initiated a comprehensive review of strategic alternatives and established a Strategic Review Committee. The review will ...

Kenvue (KUVE) has named Kirk Perry, a current director, as its interim CEO, effective immediately. Concurrently, Thibaut Mongon has left the company and resigned from the Kenvue Board. Perry, who ...

The Summit, N.J., drugmaker on Monday named director Kirk Perry interim chief executive officer after Mongon's departure from the company and board. The company also said a strategic review is ...

CEO and board member Thibaut Mongon has stepped down, it said on Monday and named company director Kirk Perry as interim chief executive. The company, which was spun off from Johnson & Johnson ...

After years of post-COVID-19 normalization and the impact of its Kenvue spinoff, Johnson & Johnson’s (NYSE: JNJ) stock price ...

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

Trump ramped up trade tensions over the weekend, vowing to slap a 30% tariff on most imports from the European Union and ...

US stocks rose on Monday with the Nasdaq closing at a fresh record with Trump's tariffs in focus as key inflation data and ...

US markets opened lower on Monday as fresh 30% tariff threats from President Trump on EU and Mexico imports weighed on ...